USAEUROPEViVE
ABOUTSPONSORSHIPFOUNDATION
Logo Hlth
Logo Hlth
01 Mar 2022 | 03:45 PM GMT

DTx - Payers & Employers

Anchored by:

Rick Bartels
President/Founder
DTXCC
Jo Masterson
CEO
2MORROW, INC.

Participants:

Jo Masterson CEO2Morrow, Inc.
Jo Masterson
CEO2Morrow, Inc.
Rick Bartels President/Founder DTxCC
Rick Bartels
President/Founder DTxCC
Brian Mahony Chief Commercial OfficerOutput Sports
Brian Mahony
Chief Commercial OfficerOutput Sports
Celine Vignal Co-FounderNeurodigitX
Celine Vignal
Co-FounderNeurodigitX
Ivan Jurisic Head of ProductPatients Influence
Ivan Jurisic
Head of ProductPatients Influence
Jin Lee Director of Digital HealthAstellas Pharma, Inc
Jin Lee
Director of Digital HealthAstellas Pharma, Inc
Marina Simonian Head of Product, Co-FounderUptiv Health
Marina Simonian
Head of Product, Co-FounderUptiv Health
Mike Pace Founder & CEOPalmHealthCo
Mike Pace
Founder & CEOPalmHealthCo
Monica Bush Global Product Marketing DirectorGE HealthCare
Monica Bush
Global Product Marketing DirectorGE HealthCare

About this Meeting

DTx solutions are becoming increasingly popular in the healthcare industry as they can improve patient outcomes, reduce healthcare costs and improve access to care. How are Payers and Employers responding to these new digital therapies? As a driver in DTx, what are the do’s and don’ts when approaching Payers and Employers for reimbursement?

 In this meeting, we will explore how DTx companies have found their launch into the market and how they get paid through Employers and Payers, bringing examples of these partnerships. Join your peers to discuss the following: 

  •  What are the differences between the US and EU and how you approach these markets differently depending on the geography 
  •  What solutions are Employers and Payers reimbursing? 
  •  Current Partnerships and what we can learn from them 
  •  Recent news on Payers not covering DTx (e.g. Aetna and Anthem announcements) - What are the challenges deriving from this news? 
  •  What are the implications of this route to market (evidence requirements, pricing strategies, etc)?